![Evaluating the role of leukotriene-modifying drugs in asthma management: Are their benefits 'losing in translation'? - ScienceDirect Evaluating the role of leukotriene-modifying drugs in asthma management: Are their benefits 'losing in translation'? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1094553916301006-gr1.jpg)
Evaluating the role of leukotriene-modifying drugs in asthma management: Are their benefits 'losing in translation'? - ScienceDirect
![Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy - Journal of Allergy and Clinical Immunology Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2005239913/2022320620/gr2.jpg)
Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy - Journal of Allergy and Clinical Immunology
![Frontiers | Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ | Pharmacology Frontiers | Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ | Pharmacology](https://www.frontiersin.org/files/Articles/435933/fphar-10-00263-HTML/image_m/fphar-10-00263-g001.jpg)
Frontiers | Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ | Pharmacology
![The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field | SpringerLink The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00228-017-2242-2/MediaObjects/228_2017_2242_Fig1_HTML.gif)
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field | SpringerLink
![Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity - Journal of Biological Chemistry Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2ce73c91-8b6a-40d9-93dd-a7a0c049069d/gr1.jpg)
Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity - Journal of Biological Chemistry
![Lecture on pharmacology for 3-rd year students of medical institute Gluschenko N.V. Sumy State University. - ppt download Lecture on pharmacology for 3-rd year students of medical institute Gluschenko N.V. Sumy State University. - ppt download](https://images.slideplayer.com/12/3385122/slides/slide_44.jpg)